“There is an expansion of global and regional immunization programs addressing viruses like Covid-19 as well as the seasonal flu and other pediatric vaccine requirements. Simultaneously, mounting safety concerns around the risk of needle stick injuries among healthcare providers are driving higher safety standards and as a result, greater interest in no-pierce, rigid plastic caps over plain rubber shields. Especially in applications that require nurses and doctors to perform many vaccinations in a short amount of time, an RNS offers more comfortable syringe handling and reduces the risk of needle sticks,” said, Carina van Eester, Global Product leader.
In countries throughout Europe, the Middle East, and Asia where infusion therapies continue to be packaged in rigid plastic containers, infusion discs are highly necessary components for treatments of chronic illnesses, infectious diseases, dehydration, post-surgery treatments, and the administration of antibiotics. Available in a wide range of sizes and configurations, Datwyler’s infusion discs are manufactured at the company’s Advanced production level and in dimensions that align with ISO 15759 as well as in other customized designs out of its newly acquired facility in Shandong, China—Yantai Xinhui Packing. The range of discs offers excellent functional properties compared to market alternatives including exceptional penetration force, resistance to fragmentation, and resealability. The discs rubber formulation also complies with international compendial requirements. The addition of infusion discs completes Datwyler’s product portfolio for IV system components, which also includes injection sites, sleeve stoppers, and vascular seals for peripheral venous catheters.